VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 13 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $266,000 | -88.7% | 286,972 | -86.4% | 0.02% | -92.5% |
| Q4 2017 | $2,352,000 | +4800.0% | 2,115,873 | +8185.5% | 0.21% | +7033.3% |
| Q2 2017 | $48,000 | -85.9% | 25,537 | -85.3% | 0.00% | -83.3% |
| Q1 2017 | $340,000 | -48.3% | 173,479 | -1.6% | 0.02% | -52.6% |
| Q4 2016 | $658,000 | -54.7% | 176,384 | -49.5% | 0.04% | -29.6% |
| Q3 2016 | $1,452,000 | -40.3% | 349,096 | -44.0% | 0.05% | -57.5% |
| Q2 2016 | $2,431,000 | – | 623,317 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|